Abstract
Cancer, known to be the most disastrous disease worldwide, accounts for about 7.6 million mortalities per year. Developing nations are facing more incidences of cancer and represent about 60% of the deaths. Researchers and scientists in the pharmaceutical industries are conducting extensive investigations to develop a definitive drug that can destroy tumors without affecting normal healthy cells. Phytochemicals possess significant anticancer potential, and their consumption is associated with the reduction of the progression of some cancers, but they have some limitations for being target-effective drugs, such as lower solubility, poor penetration power, restricted therapeutic potential, and ready absorption by normal cells. The impact of nanotechnology has significantly increased in various fields of science, especially the medical sciences, in the progress for target-specific drug release systems. Some promising nano-phytochemicals and nano-compounds, ensured by their significant cytotoxicity on various cancers, provide a novel approach in management and improvement of potent chemopreventive cancer drugs that are target specific to cancerous cells only. This chapter aims to summarize the anticancer properties of some potent phytochemicals, their mode of action, and some recent progress on nano-phytochemical-based nano-medicines and their effectiveness compared to the pure phytochemicals in the future treatment of various cancers.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
20.1 Phytochemicals and Nano-phytochemicals as Potent Anticancer Agents
Cancer remains a universal destructive disease and the second most common cause of death in humans. Approximately 7.6 million mortalities per year are attributed to cancer. Developing nations are facing more cancer incidence and now represent about 60% of the deaths (Siegel et al. 2017). The World Health Organization has predicted that about 15 million new incidences of cancer will emerge globally in 2020. Anticancer activity is the consequence of natural or synthetic compounds to reverse, repress, or check the development of cancer. As the present radiotherapy and chemotherapy treatments do not distinguish normal cells from cancer cells and thus can cause severe side effects, researchers and the pharmaceutical industry are concerned to develop a smart drug that can cure this destructive disease without affecting normal healthy cells (Jafri et al. 2018). Fortunately, India is a vast resource of medicinal plants and natural products. Epidemiological observation suggests that Indian herbs, spices, and their isolated phytochemicals possess significant anticancer potential and that their consumption is associated with reduction of the progression of some cancers. The anticancer properties of several phytochemicals isolated from different medicinal plants have been reported. Table 20.1 depicts the anticancer properties of some potent phytochemicals and their anticancer mechanisms.
20.2 The Advantage of Nano-phytochemicals Over Pure Phytochemicals
Phytochemicals have potential ability to protect against many chronic diseases such as heart disease, diabetes, neuronal degeneration, and cancer (Subramanian et al. 2016). Phytochemicals possess significant antiproliferative and apoptotic effects against various cancer cells and are widely used in anticancer research (Fig. 20.1). These phytochemicals induce apoptotic effects on various cancerous cells through different apoptotic signaling pathways and check cell-cycle progression, regulating the antioxidant system and detoxification.
Although the phytochemicals possess marvelous antiproliferative and apoptotic potential, they also have some limitations to be target-effective drugs because of their lower solubility in water, poor penetration power for entering targeted cells, restricted therapeutic potential, hepatic disposition, and prompt absorption by normal cells (Bhadoriya et al. 2011). Hence, to overcome these issues, scientists have shifted their interests toward a nano-based targeted drug delivery system of some promising phytochemicals to enhance their aqueous solubility, target specific to cancerous cells, improving cellular uptake, bioavailability and reducing the quantities of phytochemicals to achieve a secure therapeutic level of these potent phytochemicals for future targeted drug delivery systems (Fig. 20.2). The nano-phytochemicals also have various advantages over the pure phytochemicals in having excellent stability in the blood, a multi-efficient design, and hence improved anticancer effectiveness compared to the pure phytochemicals.
20.2.1 Role of Nanoform Phytochemicals in Cancer Research
Nanotechnology has improved the bioavailability, solubility, and targeted delivery of active phytochemicals by using nanoparticles as a carrier and enhancing the bioactivity of potent phytochemicals (Nishiyama 2007). There are some previous reports of the active phytochemical-loaded nanoparticles targeting against cancer cells with reduced side effects. Table 20.2 shows some promising nano-phytochemicals and their anticancer potential against some cancers.
20.2.1.1 Broccoli Gold Nanoparticles
Broccoli (Brassica oleracea) is a cruciferous vegetable that is potentially protective against some cancers (Steinmetz and Potter 1991a, b). Broccoli phytochemicals are loaded with polyphenols, glucosinolates (GLs), vitamin C, carotene, folic acid, and fibers (Conaway et al. 2001; Mahn and Reyes 2011). These constituents enhance antioxidant activities and stimulate phase-2 detoxification enzymes (Tang et al. 2006; Qazi et al. 2010). Broccoli-loaded gold nanoparticles (B-Au NPs) were synthesized and were analyzed against some cancerous cells, such as MDA-MB-231, SkBr3, and T47D cells of breast carcinoma, PC-3 cells of prostate carcinoma, and U266 cells of myeloma to evaluate the anti-cancerous activity (Khoobchandani et al. 2013). The findings revealed that the conjugated B-Au NPs possessed excellent anti-cancerous effects against breast carcinoma, prostate carcinoma and myeloma cells.
20.2.1.2 Gold Quercetin Nanoparticles
Quercetin is a predominant flavone that possesses antioxidant and antiinflammatory properties and provides valuable health benefits to humans (Aguirre et al. 2011). It is isolated from many food items such as leafy vegetables, citrus fruits, red wine, green tea, apples, berries, onions, and Ginkgo biloba (Davis et al. 2009). A previous study reported the synthesis of gold-quercetin nanoparticles (GQ NPs) and its anticancer activity against liver carcinoma (Ren et al. 2017). The GQ NPs regulated abnormal proliferation, colony formation, and cell migration in liver cancer cells, and subsequently inhibited cancer progression. GQ NPs encouraged apoptosis in liver carcinoma cells by activation of caspases (3, 9) and expression of cytochrome c (Cyto-c). The study showed that GQ NPs impair the caspase/Cyto-c pathway, obstruct NF-κB/COX-2 and Akt/ERK1/2, and suppress AP-2β/hTERT signaling pathways.
20.2.1.3 Curcumin Nanoparticles
Curcumin has both anticancer and cancer prevention properties. Curcumin is a natural bioactive polyphenolic constituent, found in turmeric, with properties to inhibit proliferation and metastasis in a wide range of cancers (Joe et al. 2004). However, poor solubility in water has limited the systemic bioavailability of curcumin when administered orally. To overcome the solubility and bioavailability restrictions of curcumin, it was loaded on various types of nanoparticles. Methoxy polyethylene glycol (mPEG) and polycaprolactone (PCL) co-polymers enhanced the anti-cancerous activity of curcumin with efficient loading capability and sustainable release in A549 cells of lung epithelial carcinoma. This curcumin-loaded nanoparticle effectively enters into lung carcinoma A549 cells and interacts with the nucleus to encourage apoptosis (Yin et al. 2013). Poly lactic-co-glycolic acid curcumin nanoparticles (PLGA-CUR NPs) showed tumor regression properties against prostate carcinoma cells by inhibiting colony formation and cell growth in prostate cancer cell xenografted mice (Yallapu et al. 2014). PLGA-CUR NPs conjugated with epidermoid growth factor receptor were targeted to GE11 peptides in breast carcinoma cells in vitro and in a tumorous mice model. It extended the epidermal growth factor receptor (EGFR) expression in MCF-7 cells of breast carcinoma and reduced the phosphoinositide-3 kinase pathway, suppressed tumor growth, suppressed cancer cell proliferation, and improved drug clearance from the circulation (Jin et al. 2017). Curcumin-loaded magnetic nanoparticles were also significantly taken up in MDA-MB-231 cells of human epithelial breast carcinoma. These nanoparticles showed strong anticancer activity via strong penetration power into the cell by endocytosis (Yallapu et al. 2012). The uploaded curcumin magnetic nanoparticles exhibited strong magnetic resonance properties and potentially enhanced the anticancer targeting capacity of curcumin.
Nano-curcumin effectively decreased the level of miRNA-21, β-catenin, and the expression of E6/E7 HPV oncoproteins in a mouse cervical cancer model (Zaman et al. 2016). Also, curcumin-loaded silica nanoparticles (Dinda et al. 2012) and curcumin-loaded folate-modified chitosan nanoparticles (Esfandiarpour-Boroujeni et al. 2017) have significant anticancer effect against HepG2 cells of hepatocellular carcinoma and MCF-7 cells of breast carcinoma, respectively.
20.2.1.4 Selaginella doederleinii Leaf Nanoparticles
Selaginella doederleinii Hieron possesses several bioactive phytochemicals and has been extensively used in traditional herbal medicine for curing rheumatoid arthritis and various cancers, specifically lung cancer, cervical cancer, choriocarcinoma, and nasopharyngeal carcinoma (Abdille et al. 2005; Ishii et al. 2005; Wang et al. 2015). Selaginella leaf extract nanoparticles (SDNPs) reduced the viability of lung carcinoma A549 cells and were least toxic to normal Chang liver cells (Syaefudin et al. 2016). The findings revealed the apoptotic potential of SDNPs and the targeted drug delivery system without affecting the normal Chang cells.
20.2.1.5 Nigella sativa Nanoformulation
Nigella sativa , commonly known as nigella, kalonji, black caraway, and black cumin, is broadly used as a traditional medicine universally (Heiss and Oeggl 2005). Thymoquinone is one of the major active phyto-constituents present in Nigella sativa and possesses various pharmacological properties: antimicrobial, antiinflammatory, antipyretic, hypoglycemic, analgesic, and antioxidant (Ali and Blunden 2003). Previous studies reported the anticancer and antimutagenic activity of thymoquinone in Caco-2, HT-29, HCT-116, DLD-1, and LoVo cancerous cells (Gali-Muhtasib et al. 2006). The encapsulated thymoquinone (TQ) nanoparticles (TQ NPs) were synthesized with the help of biodegradable polyvinyl pyrrolidone (PVP) and polyethylene glycol (PEG) (less than 50 nm in size) and significantly enhanced anticancer efficacy by increasing bioavailability and solubility (Bhattacharya et al. 2015) of TQ. In vitro study in MCF-7 cells of breast carcinoma and in vivo tumor-bearing mice demonstrated that PEG-TQ NPs enhance miR-34a, repress Rac1 mRNA protein expression, prevent cell migration, and hinder angiogenesis. TQ loaded with modified molecular micelles, PLGA nanoparticles, and chitosan myristic acid nanogel exhibited more antioxidant and antiproliferative effectiveness at low doses with controlled release as compared with pure TQ against MCF-7 cells and MDA-MB-231 of breast carcinoma (Ganea et al. 2010; Dehghani et al. 2015). These findings showed that TQ NP have a more potent apoptotic effect than pure TQ.
20.2.1.6 Honokiol Nanoparticle
Honokiol is a polyphenol, a lignan obtained from the medicinal plant Magnolia officinalis (Li et al. 2008). It possesses multifactorial pharmacological properties and is widely used to treat stomach upset, inflammation, nervous disturbance, and anxiety (Chiang et al. 2006; Kim and Cho 2008; Deng et al. 2008; Fried and Arbiser 2009). It also showed antineoplastic and apoptotic effectiveness against various cancerous cells (Yuan et al. 2009; Steinmann et al. 2012; Avtanski et al. 2013; Cheng et al. 2014; Subramaniam et al. 2015). Honokiol-loaded synthesized nanoformulation co-polymer micelles with monomethoxy polyethylene glycol and polycaprolactone (HK-MPEG/PCL) increased bioavailability and solubility. The anticancer activity of HK-MPEG/PCL showed reduced tumor growth and apoptotic induction in a cancer nude mouse model and prevented angiogenesis (Cheng et al. 2016). Another study on honokiol-loaded co-polymer synthesized with folate and polyethyleneimine nanoparticles (HK NPs) significantly prevented metastasis, proliferation, tumor growth, angiogenesis, and cell-cycle progression (Gou et al. 2010). The developed HK NPs potentially encouraged apoptosis of HNE-1 cells of nasopharyngeal carcinoma as compared to pure honokiol.
20.2.1.7 Silibinin-Loaded Nanoparticle
Silibinin is a natural antioxidant and a polyphenolic flavonoid found in Silybum marianum, also known as silybin or milk thistle (Davis-Searles et al. 2005). It possesses multifactorial pharmacological effects such as hepato-protective, antioxidant, and anticarcinogenic activities. Silibinin encourages apoptosis via inhibiting cell-cycle progression, preventing proliferation, impairs angiogenesis, and enhancing immune stimulation in several cancers (Mateen et al. 2010; Nejati-Koshki et al. 2012; Surai 2015). Some previous studies demonstrated that silibinin arrested the cancer cycle and inhibited the growth, progression, and angiogenesis of tumorous cells (Singh et al. 2006; Liang et al. 2014). Silibinin-loaded nanoparticles with PLGA-PEG co-polymer were synthesized to evaluate the anticancer potential and expression of the hTERT gene in T47D cells of breast carcinoma and A549 cells of lung carcinoma. The findings showed that hTERT expression more efficiently reduced the cell viability of both cancerous cells with the increasing concentrations of nano-silibinin as compared to the pure silibinin (Ebrahimnezhad et al. 2013; Amirsaadat et al. 2017). The silibinin-loaded phosphatidylcholine lipid nanoparticles significantly reduced the growth and angiogenesis of breast carcinoma (Xu et al. 2013). These findings suggested that nano-form silibinin was a more efficient anticancer agent than pure silibinin.
20.2.1.8 Ursolic Acid Nanoparticle
Ursolic acid is a plant-derived triterpenoid that is present in epicuticular waxes of apples, fruit peels, herbs, and spices such as rosemary and thyme (Shanmugam et al. 2013). Ursolic acid has multifactorial pharmacological properties, such as antiinflammatory (Chattopadhyay et al. 2002), antidiabetic (Jang et al. 2010), antiepileptic, anticancer (Tannock 2011), and liver protective (Shanmugam et al. 2011; Prasad et al. 2011) elements. Ursolic acid-based mesoporous silica nanospheres (UAMSN) were synthesized with the help of pH-sensitive chitosan and folic acid for the targeted drug delivery of tumor cells (Jiang et al. 2017). Enhanced apoptotic effects of ursolic acid-encapsulated PLGA nanoparticles (UA-NPs) were found in B16F10 mouse melanoma cells as compared with pure ursolic acid (Baishya et al. 2016). Folate and chitosan-based nanocarriers for the delivery of ursolic acid (FA-CS-UA-NPs) were studied for in vitro MCF-7 cells of breast carcinoma and in an in vivo tumor xenograft mouse model (Jin et al. 2016). The findings revealed FA-CS-UA-NPs penetrated into the cells via endocytosis and encouraged apoptosis. The FA-CS-UA-NPs had the potential to localize into the mitochondria, induce excessive reactive oxygen species (ROS), and enhance apoptosis in cancerous cells.
20.2.1.9 β-Lapachone Nanoparticle
Beta-lapachone is a quinone that is abundant in the bark of Tabebuia avellanedae (Lapacho tree) and has potent anti-cancerous properties (Pardee et al. 2002). It generates apoptosis via modulating NADPH quinone oxidoreductase-1 (NQO1) in cancerous cells (Blanco et al. 2007). Lapachone-loaded silver nanoparticles (Lap Au NPs) were synthesized and targeted on anti-EGFR antibody through intravenous injection of Lap Au NPs to tumor-bearing xenografted mice, showing an enhanced tumor suppression effect as well as enhanced radiotherapeutic efficacy (Jeong et al. 2009).
20.2.1.10 Ferulic Acid Nanoparticles
Ferulic acid is a phenolic phytochemical found in vegetable sources, oat flours, whole grain wheat, and rice (Zhao and Moghadasian 2008; Kumar and Pruthi 2014). A ferulic acid-loaded synthesized PLGA nanoparticle (FA-PLGA-NP) enhances apoptosis in NCI-H460 cells of lung carcinoma as compared to its pure form (Merlin et al. 2012). The FA-PLGA-NPs encourage apoptosis via decreasing cell proliferation, generating excessive intracellular ROS, enhanced DNA damage, and lipid peroxidation.
20.3 Conclusion
Numerous studies on phytochemicals have shown significant anticancer potential but some limitations. Studies on nano-phytochemicals, both in vitro and in animal models, showed enhanced bioavailability, improved cellular uptake, reduced doses, and enhanced solubility, overcoming the limitations of pure phytochemicals. Further, the potent anticancer nano-phytochemicals without side effects that are not destructive to normal cells are still to be investigated. The ongoing research on nano-phytochemicals opens a new avenue for cancer cure by following promising phytochemicals with the advanced approaches of nanotechnology.
References
Abdille MH, Singh RP, Jayaprakasha GK (2005) Antioxidant activity of the extracts from Dillenia indica fruits. Food Chem 90:891–896
Aguirre L, Arias N, Macarulla MT et al (2011) Beneficial effects of quercetin on obesity and diabetes. Open Nutraceuticals J 4:189–198
Ahamad MS, Siddiqui S, Jafri A et al (2014) Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest. PLoS One 9:e110003
Ahmad MZ, Alkahtani SA, Akhter S et al (2016) Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art. J Drug Target 24:273–293
Ali BH, Blunden G (2003) Pharmacological and toxicological properties of Nigella sativa. Phytother Res 17:299–305
Amirsaadat S, Pilehvar-Soltanahmadi Y, Zarghami F et al (2017) Silibinin-loaded magnetic nanoparticles inhibit hTERT gene expression and proliferation of lung cancer cells. Artif Cells Nanomed Biotechnol 45:1649–1656
Avtanski DB, Nagalingam A, Kupusamy P et al (2013) Targeting epithelial-mesenchymal transition in breast cancer cells using Honokiol, a natural phenolic compound. Cancer Res 73:299
Baishya R, Nayak DK, Kumar D et al (2016) Ursolic acid loaded PLGA nanoparticles: in vitro and in vivo evaluation to explore tumor targeting ability on B16F10 melanoma cell lines. Pharm Res 33:2691–2703
Bhadoriya SS, Mangal A, Madoriya N et al (2011) Bioavailability and bioactivity enhancement of herbal drugs by “Nanotechnology”: a review. J Curr Pharm Res 8:1–7
Bhattacharya S, Ahir M, Patra P et al (2015) PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a. Biomaterials 51:91–107
Blanco E, Bey EA, Dong Y et al (2007) β-Lapachone-containing PEG–PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells. J Control Release 122:365–374
Chattopadhyay D, Arunachalam G, Mandal AB et al (2002) Antimicrobial and anti-inflammatory activity of folklore: Mallotus peltatus leaf extract. J Ethnopharmacol 82:229–237
Chen YJ (2002) Potential role of tetrandrine in cancer therapy. Acta Pharmacol Sin 23:1102–1106
Cheng S, Welty M, Eliaz I et al (2014) Honokiol inhibits growth and migration of renal cell carcinoma. Cancer Res 74:3203
Cheng Y, Zheng S, Teng Y et al (2016) Preparation of honokiol with biodegradable nanoparticles for treatment of osteosarcoma. RSC Adv 6:94278–94286
Chiang CK, Sheu ML, Hung KY et al (2006) Honokiol, a small molecular weight natural product, alleviates experimental mesangial proliferative glomerulonephritis. Kidney Int 70:682–689
Conaway CC, Getachun SM, Liebes LL et al (2001) Disposition of glucosinolates and sulphoraphanes in human after ingestion of steam and fresh broccoli. Nutr Cancer 38:168–178
Davis JM, Murphy EA, Carmichael MD (2009) Effects of the dietary flavonoid quercetin upon performance and health. Curr Sports Med Rep 8:206–213
Davis-Searles PR, Nakanishi Y, Kim NC et al (2005) Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. Cancer Res 65:4448–4457
Dehghani H, Hashemi M, Entezari M et al (2015) The comparison of anticancer activity of thymoquinone and nanothymoquinone on human breast adenocarcinoma. Iran J Pharm Res 14:539
Deng J, Qian Y, Geng L et al (2008) Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (hepG2). Liver Int 28:1458–1464
Dinda AK, Prashant CK, Naqvi S et al (2012) Curcumin loaded organically modified silica (ORMOSIL) nanoparticle; a novel agent for cancer therapy. Int J Nanotechnol 9:862–871
Ebrahimnezhad Z, Zarghami N, Keyhani M et al (2013) Inhibition of hTERT gene expression by silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line. Bioimpacts 3:67
Esfandiarpour-Boroujeni S, Bagheri-Khoulenjani S, Mirzadeh H et al (2017) Fabrication and study of curcumin loaded nanoparticles based on folate-chitosan for breast cancer therapy application. Carbohydr Polym 168:14–21
Fried LE, Arbiser JL (2009) Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid Redox Signal 11:1139–1148
Gali-Muhtasib H, Roessner A, Schneider-Stock R (2006) Thymoquinone: a promising anti-cancer drug from natural sources. Int J Biochem Cell Biol 38:1249–1253
Ganea GM, Fakayode SO, Losso JN et al (2010) Delivery of phytochemical thymoquinone using molecular micelle modified poly (D, L-lactide-co-glycolide) (PLGA) nanoparticles. Nanotechnology 21:285104
Gou M, Gong C, Zhang J et al (2010) Polymeric matrix for drug delivery: Honokiol-loaded PCL-PEG-PCL nanoparticles in PEG-PCL-PEG thermosensitive hydrogel. J Biomed Mater Res Part A 93:219–226
Heiss AG, Oeggl K (2005) The oldest evidence of Nigella damascena L. (Ranunculaceae) and its possible introduction to central Europe. Veg Hist Archaeobot 14:562–570
Ishii T, Yasuda K, Akatsuka A (2005) A mutation in the SDHC gene of complex increases oxidative stress resulting in apoptosis and tumorigenesis. Cancer Res 65:203–209
Jafri A, Siddiqui S, Deep A et al (2018) Induction of apoptosis by alpha-mangostin in human hepatocellular carcinoma cells via nuclear fragmentation and ROS dependent mitochondrial pathway. J Clin Exp Hepatol 8:S116
Jafri A, Siddiqui S, Rais J et al (2019) Induction of apoptosis by piperine in human cervical adenocarcinoma via ROS mediated mitochondrial pathway and caspase-3 activation. EXCLI J 18:154–164
Jang SM, Kim MJ, Choi MS et al (2010) Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice. Metabolism 59:512–519
Jeong SY, Park SJ, Yoon SM et al (2009) Systemic delivery and preclinical evaluation of Au nanoparticle containing β-lapachone for radiosensitization. J Control Release 139:239–245
Jiang K, Chi T, Li T et al (2017) A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways. Nanoscale 9:9428–9439
Jin H, Pi J, Yang F et al (2016) Folate-chitosan nanoparticles loaded with ursolic acid confer anti-breast cancer activities in vitro and in vivo. Sci Rep 6:30782
Jin H, Pi J, Zhao Y et al (2017) EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy. Nanoscale 9:16365–16374
Joe B, Vijaykumar M, Lokesh BR (2004) Biological properties of curcumin cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 44:97–111
Kashyap D, Mondal R, Tuli HS et al (2016) Molecular targets of gambogic acid in cancer: recent trends and advancements. Tumor Biol 37:12915–12925
Kaushik U, Aeri V, Mir SR (2015) Cucurbitacins – an insight into medicinal leads from nature. Pharmacogn Rev 9:12–18
Khan F, Niaz K, Maqbool F et al (2016) Molecular targets underlying the anticancer effects of quercetin: an update. Nutrients 8:529
Khoobchandani M, Zambre A, Katti K et al (2013) Green nanotechnology from Brassicaceae: development of broccoli phytochemicals-encapsulated gold nanoparticles and their applications in nanomedicine. Int J Green Nanotechnol 5(1):1–15
Kim BH, Cho JY (2008) Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression 1. Acta Pharmacol Sin 29:113–122
Kim SH, Choi KC (2013) Anti-cancer effect and underlying mechanism(s) of kaempferol, a phytoestrogen, on the regulation of apoptosis in diverse cancer cell models. Toxicol Res 29:229–234
Kumar N, Pruthi V (2014) Potential applications of ferulic acid from natural sources. Biotechnol Rep 4:86–93
Kung HN, Lu KS, Chau YP (2014) The chemotherapeutic effects of lapacho tree extract: β-lapachone. Chemotherapy 3:1–5
Li Z, Liu Y, Zhao X et al (2008) Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells. Eur J Obstet Gynecol Reprod Biol 140:95–102
Li QS, Li CY, Li ZL et al (2012) Genistein and its synthetic analogs as anticancer agents. Anti-Cancer Agents Med Chem 12:271–281
Liang Z, Yang Y, Wang H et al (2014) Inhibition of SIRT1 signaling sensitizes the antitumor activity of silybin against human lung adenocarcinoma cells in vitro and in vivo. Mol Cancer Ther 13:1860–1872
Lin Y, Shi R, Wang X et al (2008) Luteolin, a flavonoid with potentials for cancer prevention and therapy. Curr Cancer Drug Targets 8:634–646
Mahn A, Reyes A (2011) An overview of health-promoting compounds of broccoli (Brassica oleracea var. italica) and the effect of processing. Food Sci Tech Int 18:503–514
Mateen S, Tyagi A, Agarwal C et al (2010) Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators. Mol Carcinog 49:247–258
Merlin JJ, Prasad NR, Shibli SM (2012) Ferulic acid loaded poly-d,l-lactide-co-glycolide nanoparticles: systematic study of particle size, drug encapsulation efficiency and anticancer effect in non-small cell lung carcinoma cell line in vitro. Biomed Prev Nutr 2:69–76
Moudi M, Go R, Yien CYS et al (2013) Vinca alkaloids. Int J Prev Med 4:1231–1235
Nejati-Koshki K, Zarghami N, Pourhassan-Moghaddam M et al (2012) Inhibition of leptin gene expression and secretion by silibinin: possible role of estrogen receptors. Cytotechnology 64:719–726
Nishiyama N (2007) Nanomedicine: nanocarriers shape up for long life. Nat Nanotechnol 2:203–204
Orlikova B, Tasdemir D, Golais F et al (2011) Dietary chalcones with chemopreventive and chemotherapeutic potential. Genes Nutr 6:125–147
Pardee AB, Li Y, Li CJ (2002) Cancer therapy with β-lapachone. Curr Cancer Drug Targets 2:227–242
Park C, Lee WS, Go SI et al (2015) Morin, a flavonoid from Moraceae, induces apoptosis by induction of BAD protein in human leukemic cells. Int J Mol Sci 16:645–659
Prasad S, Yadav VR, Kannappan R et al (2011) Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors evidence for the role of reactive oxygen species and JNK. J Biol Chem 286:5546–5557
Qazi A, Pal J, Maitah MI et al (2010) Anticancer activity of a broccoli derivative, sulforaphane, in Barrett adenocarcinoma: potential use in chemoprevention and as adjuvant in chemotherapy. Transl Oncol 3:389–399
Rahman HS, Rasedee A, Yeap SK et al (2014) Biomedical properties of a natural dietary plant metabolite, zerumbone, in cancer therapy and chemoprevention trials. Biomed Res Int 2014:920742
Rawson NE, Ho CT, Li S (2014) Efficacious anti-cancer property of flavonoids from citrus peels. Food Sci Human Wellness 3:104–109
Ren KW, Li YH, Wu G et al (2017) Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells. Int J Oncol 50:1299–1311
Roohbakhsh A, Parhiz H, Soltani F et al (2015) Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases. Life Sci 124:64–74
Shanmugam MK, Rajendran P, Li F et al (2011) Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice. J Mol Med 89:713–727
Shanmugam MK, Dai X, Kumar AP et al (2013) Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies. Biochem Pharmacol 85:1579–1587
Shukla S, Gupta S (2010) Apigenin: a promising molecule for cancer prevention. Pharm Res 27:962–978
Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7–30
Singh RP, Deep G, Chittezhath M et al (2006) Effect of silibinin on the growth and progression of primary lung tumors in mice. J Natl Cancer Inst 98:846–855
Singh BN, Shankar S, Srivastava RK (2011) Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 82:1807–1821
Srinivasan M, Sudheer AR, Menon VP (2007) Ferulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr 40:92–100
Steinmann P, Walters DK, Arlt MJ et al (2012) Antimetastatic activity of honokiol in osteosarcoma. Cancer 118:2117–2127
Steinmetz KA, Potter JD (1991a) Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 2:325–357
Steinmetz KA, Potter JD (1991b) Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 2:427–442
Subramaniam D, Ponnurangam S, Kwatra D et al (2015) Honokiol prevents colonic tumorigenesis and affects stem cell viability by affecting oncogenic YAP1 function. Cancer Res 75:1893
Subramanian AP, Jaganathan SK, Manikandan A et al (2016) Recent trends in nano-based drug delivery systems for efficient delivery of phytochemicals in chemotherapy. RSC Adv 6:48294–48314
Surai PF (2015) Silymarin as a natural antioxidant: an overview of the current evidence and perspectives. Antioxidants 4:204–247
Syaefudin JA, Rosiyana L, Setyani A et al (2016) Nanoparticles of Selaginella doederleinii leaf extract inhibit human lung cancer cells A549. Earth Environ Sci 31:1–5
Tan W, Li Y, Chen M et al (2011) Berberine hydrochloride: anticancer activity and nanoparticulate delivery system. Int J Nanomedicine 6:1773–1777
Tang L, Zhang Y, Jobson EH et al (2006) Potent activation of mitochondria-mediated apoptosis and arrest in S and M phases of cancer cells by a broccoli sprout extract. Mol Cancer Ther 5:935–944
Tannock LR (2011) Ursolic acid effect on atherosclerosis: apples and apples, or apples and oranges? Atherosclerosis 219:397–398
Ting H, Deep G, Agarwal R (2013) Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer. AAPS J 15:707–716
Tozer GM, Kanthou C, Parkins CS et al (2002) The biology of the combretastatins as tumour vascular targeting agents. Int J Exp Pathol 83:21–38
Varoni EM, Faro AFL, Sharifi-Rad J et al (2016) Anticancer molecular mechanisms of resveratrol. Front Nutr 3:1–15
Wang G, Yao S, Cheng L et al (2015) Antioxidant and anticancer effection of the volatile oil from various habitats of Selaginella doederleinii Hieron. Technol Health Care 23:S21–S27
Wei WT, Lin SZ, Liu DL et al (2013) The distinct mechanisms of the antitumor activity of emodin in different types of cancer. Oncol Rep 30:2555–2562
Woo CC, Kumar AP, Sethi G et al (2012) Thymoquinone: potential cure for inflammatory disorders and cancer. Biochem Pharmacol 83:443–451
Xu P, Yin Q, Shen J et al (2013) Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS. Int J Pharm 454:21–30
Yallapu MM, Othman SF, Curtis ET, Bauer NA, Chauhan N, Kumar D, Jaggi M, Chauhan SC (2012) Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int J Nanomedicine 7:1761
Yallapu MM, Khan S, Maher DM et al (2014) Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer. Biomaterials 35:8635–8648
Yin H, Zhang H, Liu B (2013) Superior anticancer efficacy of curcumin-loaded nanoparticles against lung cancer. Acta Biochim Biophys Sin 45:634–640
Yuan Z, Liu H, Yan F et al (2009) Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS-4, a novel pro-apoptotic gene. Cancer Sci 100:1757–1766
Zaman MS, Chauhan N, Yallapu MM et al (2016) Curcumin nanoformulation for cervical cancer treatment. Sci Rep 6:20051
Zhang HM, Zhao L, Li H et al (2014) Research progress on the anticarcinogenic actions and mechanisms of ellagic acid. Cancer Biol Med 11:92–100
Zhao Z, Moghadasian MH (2008) Chemistry, natural sources, dietary intake and pharmacokinetic properties of ferulic acid: a review. Food Chem 109:691–702
Acknowledgments
The authors Asif Jafri and Md Arshad acknowledge the support of Uttar Pradesh Council of Science and Technology, Lucknow, India (File No. CST/SERPD/D-299). Asif Jafri is also grateful to the Council of Scientific and Industrial Research, India for the award of Senior Research Fellowship (File No. 09/107 (0393)/2018- EMR-I).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jafri, A., Amjad, S., Bano, S., Kumar, S., Serajuddin, M., Arshad, M. (2020). Efficacy of Nano-phytochemicals Over Pure Phytochemicals Against Various Cancers: Current Trends and Future Prospects. In: Bhushan, I., Singh, V., Tripathi, D. (eds) Nanomaterials and Environmental Biotechnology. Nanotechnology in the Life Sciences. Springer, Cham. https://doi.org/10.1007/978-3-030-34544-0_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-34544-0_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-34543-3
Online ISBN: 978-3-030-34544-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)